Literature DB >> 1314512

Cardiac instability amplified by use-dependent Na channel blockade.

C F Starmer1, A R Lancaster, A A Lastra, A O Grant.   

Abstract

Drugs that exhibit use-dependent Na channel blockade, including antiarrhythmic agents, tricyclic antidepressants, opiate-like analgesics, and cocaine, are linked with an increased susceptibility to cardiac arrhythmias and sudden death. Computer simulations indicate that Na channel blockade retards recovery of excitability, thereby increasing the spatial dispersion of refractoriness, a precursor of many cardiac arrhythmias. In isolated rabbit left atria, stimuli timed to occur at increasing intervals following conditioning stimuli reveal an unstable interval (vulnerable period) during which single stimuli initiate trains of responses. The vulnerable period is extended by use-dependent Na channel blockade and provides a model for assaying proarrhythmic potential and probing cardiac instability.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314512     DOI: 10.1152/ajpheart.1992.262.4.H1305

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  New aspects of vulnerability in heterogeneous models of ventricular wall and its modulation by loss of cardiac sodium channel function.

Authors:  A Kapela; N Tsoukias; A Bezerianos
Journal:  Med Biol Eng Comput       Date:  2005-05       Impact factor: 2.602

2.  Effect of ajmaline on sustained ventricular tachycardia induced by programmed electrical stimulation in conscious dogs after myocardial infarction.

Authors:  H Todt; G Krumpl; N Zojer; K Krejcy; G Raberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

3.  Vulnerability in an excitable medium: analytical and numerical studies of initiating unidirectional propagation.

Authors:  C F Starmer; V N Biktashev; D N Romashko; M R Stepanov; O N Makarova; V I Krinsky
Journal:  Biophys J       Date:  1993-11       Impact factor: 4.033

4.  Comparative electrophysiological effects of the antidepressants fluvoxamine and amitriptyline in the canine heart after myocardial infarction.

Authors:  Y Ikeda; M Nishimoto; Y Shimazu; H Hashimoto; K Umemura; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

5.  Wavelet formation in excitable cardiac tissue: the role of wavefront-obstacle interactions in initiating high-frequency fibrillatory-like arrhythmias.

Authors:  J M Starobin; Y I Zilberter; E M Rusnak; C F Starmer
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

6.  Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical Evaluation.

Authors:  Gül Erdemli; Albert M Kim; Haisong Ju; Clayton Springer; Robert C Penland; Peter K Hoffmann
Journal:  Front Pharmacol       Date:  2012-01-26       Impact factor: 5.810

7.  KChIP2 is a core transcriptional regulator of cardiac excitability.

Authors:  Drew M Nassal; Xiaoping Wan; Haiyan Liu; Danielle Maleski; Angelina Ramirez-Navarro; Christine S Moravec; Eckhard Ficker; Kenneth R Laurita; Isabelle Deschênes
Journal:  Elife       Date:  2017-03-06       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.